A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis

INTRODUCTION: Natalizumab is a new humanized monoclonal antibody used in multiple sclerosis (MS). The aim of this meta-analysis was to evaluate the efficacy and tolerability of this drug in relapsing MS. PubMed, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials were searched...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Nikfar, Shekoufeh, Rahimi, Roja, Rezaie, Ali, Abdollahi, Mohammad
Format: Artigo
Jezik:Inglês
Izdano: Termedia Publishing House 2010
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3281346/
https://ncbi.nlm.nih.gov/pubmed/22371753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2010.13901
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki